Bank of America Corporation (BAC) 13D/13G Filings for Aptevo Therapeutics Inc. (APVO)

Bank of America Corporation 13D and 13G filings for Aptevo Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-06
4:26 pm
Purchase
2025-09-3013GAptevo Therapeutics Inc.
APVO
BANK OF AMERICA CORP
BAC
494,341
15.000%
494,341increase
(New Position)
Filing